Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Biocept Inc. (OTC : BIOCQ) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Biocept Inc develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for treating and monitoring patients diagnosed with a variety of cancers. In addition to its portfolio of blood-based liquid biopsy assays, Biocept has developed the CNSide cerebrospinal fluid assay that detects cancer that has metastasized to the central nervous system. Biocept's patented Target Selector technology captures and quantitatively analyzes CSF tumor cells for tumor-associated molecular markers, using technology first developed for use in blood. It is also leveraging its molecular diagnostic capabilities to offer nationwide COVID-19 RT-PCR testing to support public health efforts during this unprecedented pandemic.
Quote
| Last: | $0.0002 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $0.0002 |
| Close: | $0.0002 |
| High: | $0.0002 |
| Low: | $0.0002 |
| Volume: | 203 |
| Last Trade Date Time: | 06/03/2026 09:35:17 am |
Stock Data
| Market Cap: | $263 |
|---|---|
| Float: | 2,583,736 |
| Insiders Ownership: | 3% |
| Institutions: | 3 |
| Short Percent: | 14999% |
| Industry: | Medical Diagnostics & Screening |
| Sector: | Healthcare |
| Website: | https://www.biocept.com |
| Country: | US |
| City: | San Diego |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Biocept Inc. (OTC: BIOCQ).
